Summer Sale

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Get 30% Off

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Min Hee Hong

Assistant Professor

Yonsei Cancer Center

South Korea

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Immunology

30%

Pharmacotherapy

30%

Cancer Biology

60%

Cancer Therapy

40%

Oncology

40%

Tyrosine Kinase

30%

Prognostic Biomarker

30%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles11

Clinical Outcomes of Thymic Carcinoma: The Role of Radiotherapy Combined with Multimodal Treatments

Article Link

Year:

2023

Polo-like Kinase 4: A Multifaceted Marker Linking Tumor Aggressiveness and Unfavorable Prognosis, and Insights into Therapeutic Strategies

Article Link

Year:

2023

Genetic Analysis and Operative Outcomes in Patients with Oncogene-Driven Advanced NSCLC Treated with Cytoreductive Surgery as a Component of Local Consolidative Therapy

Article Link

Year:

2021

Intracranial failure after hippocampal-avoidance prophylactic cranial irradiation in limited-stage small-cell lung cancer patients

Article Link

Year:

2021

Overexpression of PVR and PD-L1 and its association with prognosis in surgically resected squamous cell lung carcinoma

Article Link

Year:

2021

Analyses of CNS Response to Osimertinib in Patients with T790M-Positive Advanced NSCLC from ASTRIS Korean Subset, Open-Label Real-World Study

Article Link

Year:

2021

Distinct Characteristics and Clinical Outcomes to Predict the Emergence of <i>MET</i> Amplification in Patients with Non-Small Cell Lung Cancer Who Developed Resistance after Treatment with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors

Article Link

Year:

2021

Blocking TIM-3 in Treatment-refractory Advanced Solid Tumors: A Phase Ia/b Study of LY3321367 with or without an Anti-PD-L1 Antibody

Article Link

Year:

2021

Overexpression of poliovirus receptor is associated with poor prognosis in head and neck squamous cell carcinoma patients

Article Link

Year:

2021

Real-world outcomes of anti-PD1 antibodies in platinum-refractory, PD-L1-positive recurrent and/or metastatic non-small cell lung cancer, and its potential practical predictors: first report from Korean Cancer Study Group LU19-05

Article Link

Year:

2021

Treatment Patterns and Clinical Outcomes in Korean Cancer Patients With Venous Thromboembolism: A Retrospective Cohort Study

Article Link

Year:

2021

Collaborators8

Kyoung-Ho Pyo

Yonsei University College of Medicine

SOUTH KOREA

Kyung Hwan Kim

Professor

Yonsei University Health System

SOUTH KOREA

Jee Hung KIM

Yonsei University Health System

SOUTH KOREA

Ji Hyun Lee

Clinical assistant professor

Catholic University of Korea Eunpyeong St Mary's Hospital

SOUTH KOREA

Hong In Yoon

Yonsei University College of Medicine

SOUTH KOREA

Byung Jo Park

clinical assistant professor

Yonsei University College of Medicine

SOUTH KOREA

Jaeho Cho

Professor

Yonsei University College of Medicine

SOUTH KOREA

Hyo Sup Shim

Yonsei University College of Medicine

SOUTH KOREA

How do I reach out?

Meet Kite AI